We are live on ! Find out more

SenesTech

SNES

Market cap $5.86M

1.08 USD

+0.07

6.93%

At close Updated Oct 30, 4:00 PM EDT

Pre-market

After hours

1.08

0.00

0%

1 day

6.93%

5 days

30.12%

1 month

59.6%

3 months

-18.18%

6 months

-23.94%

Year to date

-51.13%

1 year

-67.76%

5 years

-99.97%

10 years

-100%

About: SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company has developed and are commercializing products for managing animal pest populations through fertility control and population management strategies. Its current products focus on rat and mouse populations, and are known as: ContraPest, Evolve Rat, and Evolve Mouse.

Employees: 24

Materials Specialty Chemicals

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 100%

Negative 0%

Sandstrom Partners Hired As Strategic Advisor on Marketing and Branding

SURPRISE, Ariz., Oct. 28, 2026 (GLOBE NEWSWIRE) -- SenesTech, Inc. (NASDAQ: SNES), an innovator in rodent control, today announced that it has engaged Portland, Oregon-based Sandstrom Partners, Inc. ("Sandstrom") as a strategic advisor with the goal of accelerating sales.

Sandstrom Partners Hired As Strategic Advisor on Marketing and Branding

SenesTech: Sandstrom Partners Hired As Strategic Advisor on Marketing and Branding

Portland-Based Experts on Brand and Marketing Strategy Will Help SenesTech Pursue E-Commerce and B2B Sales-Growth Opportunities Portland-Based Experts on Brand and Marketing Strategy Will Help SenesTech Pursue E-Commerce and B2B Sales-Growth Opportunities

SenesTech: Sandstrom Partners Hired As Strategic Advisor on Marketing and Branding

SenesTech Receives Nasdaq Minimum Bid Price Notification and Highlights Record Third Quarter Revenue

SURPRISE, Ariz., Oct. 22, 2026 (GLOBE NEWSWIRE) -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that, on Oct. 20, 2026, it received a letter from the listing qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the closing bid price of its common stock had been below $1.00 per share for 30 consecutive business days. As a result, the Company does not currently meet the minimum bid price requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2).

SenesTech Receives Nasdaq Minimum Bid Price Notification and Highlights Record Third Quarter Revenue

GLENBROOK CROSSES 30% OWNERSHIP OF SENESTECH

Glenbrook Believes Better Market Strategy and Sharpened Capitalization Focus Would Create Significant Upside MINDEN, Nev., Oct. 19, 2026 /PRNewswire/ -- Glenbrook Capital Management ("Glenbrook"), a long-time shareholder of SenesTech, Inc. (NASDAQ: SNES) (the "Company") and owners of over 30% of outstanding shares of the Company, today issued the following letter.

GLENBROOK CROSSES 30% OWNERSHIP OF SENESTECH

SenesTech Reports 88% Reduction in Rat Activity in Chicago Pilot, Building on Record $1.1 Million Quarterly Revenue Milestone

Rodent-Related 311 Calls in Deployment Area Fell 36% While Citywide Calls Increased Evolve® Rat Bith Control TM Expands to Six Chicago-Area SSAs and Wards SURPRISE, Ariz., Oct. 19, 2026 (GLOBE NEWSWIRE) -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced results from a pilot of Evolve® Rat Birth Control™ in Chicago's Wicker Park Bucktown Special Service Area (SSA) #33.

SenesTech Reports 88% Reduction in Rat Activity in Chicago Pilot, Building on Record $1.1 Million Quarterly Revenue Milestone

SenesTech Reports Record Preliminary Third Quarter Revenue Exceeding $1 Million, the Highest in Company History, with 40% Sequential Growth

Preliminary Revenue of $1.1 Million is the Highest Quarterly Revenue in the Company's History SURPRISE, Ariz., Oct. 15, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced preliminary revenue results for the third quarter of 2026.

SenesTech Reports Record Preliminary Third Quarter Revenue Exceeding $1 Million, the Highest in Company History, with 40% Sequential Growth

SenesTech Expands Third-Party E-commerce Distribution with Grove Collaborative, Bringing Evolve® Rodent Birth Control™ Products to Sustainability-Focused Consumers

SURPRISE, Ariz., Sept. 23, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that its Evolve® family of rodent birth control products will soon be available through Grove Collaborative's online marketplace.

SenesTech Expands Third-Party E-commerce Distribution with Grove Collaborative, Bringing Evolve® Rodent Birth Control™ Products to Sustainability-Focused Consumers

SenesTech to Participate in the Lytham Partners Fall 2026 Investor Conference

PHOENIX, Sept. 17, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2026 Investor Conference, taking place virtually on September 29-30, 2026.

SenesTech to Participate in the Lytham Partners Fall 2026 Investor Conference

Swampscott Municipal Integrated Pest Management Program Achieves 43% Reduction in Rodent Activity with Evolve® Rat

SURPRISE, Ariz., Aug. 31, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that a six-month deployment of Evolve® Rat as part of a comprehensive Integrated Pest Management program reduced measured rodent activity by 43% at a municipal facility in Swampscott, Massachusetts.

Swampscott Municipal Integrated Pest Management Program Achieves 43% Reduction in Rodent Activity with Evolve® Rat

SenesTech Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SURPRISE, Ariz., Aug. 27, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that its Board of Directors has granted an inducement equity award to John Karabees in connection with his appointment as Executive Vice President, Sales.

SenesTech Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

See News Rankings

Price charts implemented using Lightweight Charts™